Literature DB >> 29626475

FGF8 and FGFR3 are up-regulated in hypertrophic chondrocytes: Association with chondrocyte death in deep zone of Kashin-Beck disease.

Huizhong Liu1, Qian Fang1, Mengying Wang1, Wenjun Wang1, Meng Zhang1, Dan Zhang1, Ying He1, Ying Zhang1, Hui Wang1, Miguel Otero2, Tianyou Ma1, Jinghong Chen3.   

Abstract

OBJECTIVE: The aim of this study was to investigate FGF8 and FGFR3 expression in clinical samples of Kashin-Beck disease (KBD), an endemic osteochondropathy found in China, as well as in pre-clinical models of this disease.
METHOD: Cartilage was collected from the hand phalanges of five patients with KBD and from five healthy children. Sprague-Dawley rats were administered a selenium-deficient diet for four weeks prior to exposure to the T-2 toxin. ATDC5 cells were differentiated into hypertrophic chondrocytes for twenty-one days, and then treated with 3-morpholinosydnonimine (SIN-1) (0, 1, 3, or 5 mM) for 24 h. FGF8 and FGFR3 were visualized using immunohistochemistry; protein levels were assessed by western blotting, and mRNA levels were determined by real-time RT-PCR.
RESULTS: Increased staining of FGF8 and FGFR3 was observed in the cartilage of children with KBD compared to normal children. Both increased FGF8 and FGFR3 staining, as well as protein levels, were also observed in the cartilage of rats fed normal or Se-deficient diets plus T-2 toxin exposure, compared to those in rats fed with normal or Se-deficient diets alone. SIN-1 treatment of hypertrophic chondrocytes (ATCD5 cells) increased FGF8 and FGFR3 protein and mRNA levels in a dose-dependent manner.
CONCLUSION: Our data indicate that SIN-1 induces FGF8 and FGFR3 overexpression and this is involved in the abnormal terminal differentiation and degradation of the ECM in cartilage. FGF8 and FGFR3 may therefore play an important role in the onset of deep zone necrosis and pathogenesis in KBD in adolescent children.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Differentiation disorder; Fibroblast growth factor 8; Fibroblast growth factor receptor-3; Oxidative stress

Mesh:

Substances:

Year:  2018        PMID: 29626475     DOI: 10.1016/j.bbrc.2018.04.023

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Upregulated expression of transforming growth factor-β receptor I/II in an endemic Osteoarthropathy in China.

Authors:  Ying Zhang; Yudong Mu; Ying He; Zhengzheng Li; Ge Mi; Yinan Liu; Meng Zhang; Hui Wang; Yiping Feng; Qian Fang; Tianyou Ma; Xianghua Deng; Jinghong Chen
Journal:  BMC Musculoskelet Disord       Date:  2021-12-20       Impact factor: 2.362

Review 2.  The role of fibroblast growth factor 8 in cartilage development and disease.

Authors:  Haoran Chen; Yujia Cui; Demao Zhang; Jing Xie; Xuedong Zhou
Journal:  J Cell Mol Med       Date:  2022-01-09       Impact factor: 5.310

3.  Magnetic resonance imaging at 7.0 T for evaluation of early lesions of epiphyseal plate and epiphyseal end in a rat model of Kashin-Beck disease.

Authors:  Yong Li; Pengde Kang; Zongke Zhou; Fuxing Pei; Qing He; Dike Ruan
Journal:  BMC Musculoskelet Disord       Date:  2020-08-12       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.